Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program

NCT06901362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 401

Last updated 2025-12-23

No results posted yet for this study

Summary

This study is a cross-sectional study. The study aims to determine the levels of immunity against hepatitis B virus and varicella-zoster virus in medical students.

Conditions

  • Healthy
  • Healthy Adult

Sponsors & Collaborators

  • Thammasat University Hospital

    collaborator OTHER
  • Thammasat University

    lead OTHER

Principal Investigators

  • Narongkorn Saiphoklang, MD · Thammasat University Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-08-31
Completion
2025-11-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06901362 on ClinicalTrials.gov